New Zealand markets open in 7 hours 29 minutes

MRNA Jan 2024 250.000 put

OPR - OPR Delayed price. Currency in USD
Add to watchlist
132.830.00 (0.00%)
As of 03:47PM EDT. Market open.
Full screen
Previous close132.83
Expiry date2024-01-19
Day's range132.83 - 132.83
Contract rangeN/A
Open interestN/A
  • Yahoo Finance

    Novavax expects COVID-19 boosters to be available next week

    Novavax gets green light from FDA, awaits CDC recommendation for booster COVID doses.

  • Yahoo Finance

    Behind the new malaria vaccine endorsed by the World Health Organization

    The Serum Institute of India has received a recommendation from WHO for malaria doses using a Novavax adjuvant.

  • Financial Times

    Moderna reports trial success for dual Covid and flu vaccine

    Moderna’s combined Covid and influenza vaccine was as effective as separate shots in an early stage trial, giving the US biotech company hope that the more convenient way of protecting against the diseases could be approved by 2025. Interim data measuring antibody levels from the phase-1/2 trial showed the combined jab elicited a similar or greater immune response to flu viruses as currently approved flu vaccines, including Sanofi’s high-dose shots designed for the elderly. The jab also elicited a similar immune response to Sars-Cov-2 as Moderna’s Covid-19 booster, known as Spikevax.